
Keywords: TAFI; thrombin-activatable fibrinolysis inhibitor; TAFIa; activated thrombin-activatable fibrinolysis inhibitor; SDS; sodium dodecyl sulfate; PolyP; polyphosphate; PPACK; H-D-Phe-Pro-Arg-chloromethylketone; CMC; critical micelle concentration; Carboxypept